Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 1997

View Archived Issues

Hair growth stimulants from Tanabe

Nisshin Flour Milling claims antidiabetic compounds

Company Profile: DepoTech Corp.

Novel myocardial protectant described by Taiwanese researchers

Searle describes new platelet aggregation inhibitors

New psychopharmacological agents developed by Ferrer

Novel allergy agent claimed by French researchers

GRF analogues developed for growth hormone deficiencies

COX-2 inhibitors reported by Merck Frosst

Pharmacia & Upjohn claims camptothecin derivatives

Antibacterial and antineoplastic agents developed by Abbott

Thrombin inhibitors from BioChem Pharma

RPR discloses novel polypeptides for cancer

Spotlight on influenza sialidase inhibitors

Novartis selects analgesic agent as clinical candidate

Korean investigators isolate natural antioxidant

Orally active anti-PCP agents developed by U.S. investigators

Enantiospecific synthesis of SP antagonist from RPR

Mediolanum prepares novel quinolone antibacterial agents

NAChR agonist SIB-1765F: Potential antiparkinsonian agent

Spanish pharmaceutical merger confirmed

Hypocholesterolemic activity of raloxifene established in rats

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Preliminary results for potential new anti-HIV combination presented

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Clinical data on AccuSite published in peer-reviewed journals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...